KR20110086742A - 모노카밤 - Google Patents

모노카밤 Download PDF

Info

Publication number
KR20110086742A
KR20110086742A KR1020117013944A KR20117013944A KR20110086742A KR 20110086742 A KR20110086742 A KR 20110086742A KR 1020117013944 A KR1020117013944 A KR 1020117013944A KR 20117013944 A KR20117013944 A KR 20117013944A KR 20110086742 A KR20110086742 A KR 20110086742A
Authority
KR
South Korea
Prior art keywords
compound
formula
amino
mmol
pharmaceutically acceptable
Prior art date
Application number
KR1020117013944A
Other languages
English (en)
Korean (ko)
Inventor
스티븐 조셉 브리크너
마크 에드워드 플라나간
맨진더 싱 롤
Original Assignee
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드 filed Critical 화이자 인코포레이티드
Publication of KR20110086742A publication Critical patent/KR20110086742A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020117013944A 2008-12-19 2009-12-07 모노카밤 KR20110086742A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13915908P 2008-12-19 2008-12-19
US61/139,159 2008-12-19

Publications (1)

Publication Number Publication Date
KR20110086742A true KR20110086742A (ko) 2011-07-29

Family

ID=41727494

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117013944A KR20110086742A (ko) 2008-12-19 2009-12-07 모노카밤

Country Status (15)

Country Link
US (2) US8252782B2 (pt-PT)
EP (1) EP2379546A1 (pt-PT)
JP (1) JP2012512863A (pt-PT)
KR (1) KR20110086742A (pt-PT)
CN (1) CN102325769A (pt-PT)
AR (1) AR074801A1 (pt-PT)
AU (1) AU2009329169B2 (pt-PT)
CA (1) CA2744756C (pt-PT)
IL (1) IL213216A0 (pt-PT)
MX (1) MX2011006541A (pt-PT)
PA (1) PA8855001A1 (pt-PT)
SG (1) SG171781A1 (pt-PT)
TW (1) TW201026696A (pt-PT)
UY (1) UY32336A (pt-PT)
WO (1) WO2010070523A1 (pt-PT)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102325769A (zh) * 2008-12-19 2012-01-18 美国辉瑞有限公司 单卡波姆
JP5777725B2 (ja) * 2010-11-29 2015-09-09 ファイザー・インク モノバクタム
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
AU2016327264B2 (en) 2015-09-23 2019-06-27 Novartis Ag Salts and solid forms of monobactam antibiotic
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
BR112019012994A2 (pt) 2016-12-21 2019-12-03 Aicuris Gmbh & Co Kg terapia de combinação com compostos de b-lactama de amidina substituída e inibidores de b-lactamase para infecções com cepas bacterianas resistentes a antibiótico
US11414411B2 (en) 2017-08-02 2022-08-16 Novartis Ag Chemical process for manufacturing monobactam antibiotic and intermediates thereof
JP7244493B2 (ja) 2017-08-23 2023-03-22 ヘルムホルツ－ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー 新規なシストバクタミド誘導体
CN111328327A (zh) 2017-08-31 2020-06-23 北兴化学工业株式会社 1-(n,n-二取代的氨基甲酰基)4-(取代的磺酰基)三唑啉-5-酮衍生物、4-(n,n-二取代的氨基甲酰基)1-(取代的磺酰基)三唑啉-5-酮衍生物和包含这些衍生物作为有效成分的除草剂
US11459323B2 (en) 2018-01-29 2022-10-04 Medshine Discovery Inc. Monocyclic β-lactam compound for treating bacterial infection
EP4079305A4 (en) 2019-12-19 2024-01-10 Shenzhen Optimum Biological Technology Co., Ltd APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
JPH02502378A (ja) 1987-02-11 1990-08-02 ジ・アップジョン・カンパニー 抗生物質としての新規なＮ‐１置換β‐ラクタム
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4889930A (en) 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
EP0336369A1 (en) 1988-04-04 1989-10-11 E.R. Squibb & Sons, Inc. 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones
EP0344707A3 (en) 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
WO1990003376A1 (en) 1988-09-27 1990-04-05 The Upjohn Company Dihydroxyaryl 4-substituted monocarbams as antibiotics
CA2210787A1 (en) 1997-07-17 1999-01-17 William R. Collier Self-contained work station
WO2008116813A2 (en) 2007-03-23 2008-10-02 Basilea Pharmaceutica Ag Combination medicaments for treating bacterial infections
CN102325769A (zh) * 2008-12-19 2012-01-18 美国辉瑞有限公司 单卡波姆

Also Published As

Publication number Publication date
US20100160281A1 (en) 2010-06-24
CA2744756A1 (en) 2010-06-24
AU2009329169B2 (en) 2012-06-28
WO2010070523A1 (en) 2010-06-24
US20120289455A1 (en) 2012-11-15
SG171781A1 (en) 2011-07-28
EP2379546A1 (en) 2011-10-26
IL213216A0 (en) 2011-07-31
UY32336A (es) 2010-07-30
US8252782B2 (en) 2012-08-28
CN102325769A (zh) 2012-01-18
TW201026696A (en) 2010-07-16
AR074801A1 (es) 2011-02-16
AU2009329169A1 (en) 2010-06-24
JP2012512863A (ja) 2012-06-07
CA2744756C (en) 2013-05-28
US8324198B1 (en) 2012-12-04
PA8855001A1 (es) 2010-07-27
MX2011006541A (es) 2011-07-20

Similar Documents

Publication Publication Date Title
US8252782B2 (en) Monocarbams
JP2019532928A (ja) ベータラクタマーゼ阻害剤化合物
KR20130140868A (ko) 항세균제로서 유용한 이속사졸 유도체
KR20130140164A (ko) 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체
JP4064462B2 (ja) セフェム化合物及び該化合物を含有する医薬
KR20140114390A (ko) 아미딘 치환된 베타 - 락탐 화합물, 그의 제조법 및 항박테리아제로서의 용도
US10919851B2 (en) 2-pyrrolidine phenylhydrazides antibacterial agents
US12103904B2 (en) Benzoylglycine derivatives and methods of making and using same
WO2005113522A1 (en) Azole carboxamide inhibitors of bacterial type iii protein secretion systems
TWI829686B (zh) 氧基取代化合物
US20160052890A1 (en) Compounds useful as antibiotic tolerance inhibitors
JP5511824B2 (ja) 環状アミドキシムまたは環状アミドラゾン基を有する新規なオキサゾリジノン誘導体及びこれを含む医薬組成物
JP2004196678A (ja) ピラゾール系誘導体
US20200031802A1 (en) Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof
JP2008516952A (ja) ヒスタミンｈ３受容体阻害剤、製造及び治療的使用
EP2254893A1 (fr) Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
WO1994006804A1 (en) Cephem compound, process for producing the same, and medicine containing the same
WO1995025109A1 (fr) Compose de cephem, procede d'obtention de ce compose et agent antibacterien contenant celui-ci
WO2009077485A2 (en) 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
WO2023224892A1 (en) Inhibitors of msba as antibiotics, pharmaceutical compositions, and uses thereof
EP4025577A1 (en) Siderophore cephalosporin conjugates and uses thereof
AU2014276550A1 (en) Novel pyrrole derivatives
WO2000034274A1 (fr) Derives de la cyclohexylpiperidine
WO1988010263A1 (en) Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
WO2001057041A1 (fr) Composes 1-methylcarbapedem

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right